To investigate potential roles of survivin in the initiation and progression of melanoma in vivo, a transgenic mouse strain was created that provided melanocyte-specific expression of survivin under the transcriptional control of the dopachrome tautomerase (Dct) promoter [14]. The gene discussed is BIRC5; the disease is melanoma.